Description
PHARMACEUTICAL REVERSE DISTRIBUTION AND DESTRUCTION
Modification chain · 21 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2018-10-09+$194,024= $194,024
- Mod P000012018-12-14+$0= $194,024
- Mod P000022019-05-16+$25,800= $219,824
- Mod P000032019-07-03+$24,063= $243,886
- Mod P000042019-10-28+$1,213= $245,099
- Mod P000052019-12-04+$600= $245,699
- Mod P000062020-02-25-$3,100= $242,599
- Mod P000072020-04-21-$22,583= $220,017
- Mod P000082020-04-23-$2,311= $217,706
- Mod P000092020-05-05-$1,095= $216,612
- Mod P000112020-07-08-$315= $216,297
- Mod P000122021-01-13+$6,049= $222,346
- Mod P000132021-01-20+$12,777= $235,123
- Mod P000142021-03-12+$1,370= $236,493
- Mod P000152021-04-01+$757= $237,251
- Mod P000162021-04-15+$12,331= $249,581
- Mod P000172021-05-11+$710= $250,291
- Mod P000182021-06-15+$2,500= $252,791
- Mod P000192021-08-18+$5,000= $257,791
- Mod P000202021-12-22-$7,563= $250,229
- Mod P000212022-02-03-$16,071= $234,158
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2018-10-09 | +$194,024 | $194,024 | PHARMACEUTICAL REVERSE DISTRIBUTION AND DESTRUCTION |
| Mod P00001· OTHER ADMINISTRATIVE ACTION | 2018-12-14 | +$0 | $194,024 | PHARMACEUTICAL REVERSE DISTRIBUTION AND DESTRUCTION |
| Mod P00002· FUNDING ONLY ACTION | 2019-05-16 | +$25,800 | $219,824 | PHARMACEUTICAL REVERSE DISTRIBUTION AND DESTRUCTION |
| Mod P00003· FUNDING ONLY ACTION | 2019-07-03 | +$24,063 | $243,886 | PHARMACEUTICAL REVERSE DISTRIBUTION AND DESTRUCTION |
| Mod P00004· FUNDING ONLY ACTION | 2019-10-28 | +$1,213 | $245,099 | PHARMACEUTICAL REVERSE DISTRIBUTION AND DESTRUCTION |
| Mod P00005· FUNDING ONLY ACTION | 2019-12-04 | +$600 | $245,699 | PHARMACEUTICAL REVERSE DISTRIBUTION AND DESTRUCTION |
| Mod P00006· FUNDING ONLY ACTION | 2020-02-25 | −$3,100 | $242,599 | PHARMACEUTICAL REVERSE DISTRIBUTION AND DESTRUCTION |
| Mod P00007· FUNDING ONLY ACTION | 2020-04-21 | −$22,583 | $220,017 | PHARMACEUTICAL REVERSE DISTRIBUTION AND DESTRUCTION |
| Mod P00008· OTHER ADMINISTRATIVE ACTION | 2020-04-23 | −$2,311 | $217,706 | PHARMACEUTICAL REVERSE DISTRIBUTION AND DESTRUCTION |
| Mod P00009· FUNDING ONLY ACTION | 2020-05-05 | −$1,095 | $216,612 | PHARMACEUTICAL REVERSE DISTRIBUTION AND DESTRUCTION |
| Mod P00011· FUNDING ONLY ACTION | 2020-07-08 | −$315 | $216,297 | PHARMACEUTICAL REVERSE DISTRIBUTION AND DESTRUCTION |
| Mod P00012· FUNDING ONLY ACTION | 2021-01-13 | +$6,049 | $222,346 | PHARMACEUTICAL REVERSE DISTRIBUTION AND DESTRUCTION |
| Mod P00013· FUNDING ONLY ACTION | 2021-01-20 | +$12,777 | $235,123 | PHARMACEUTICAL REVERSE DISTRIBUTION AND DESTRUCTION |
| Mod P00014· FUNDING ONLY ACTION | 2021-03-12 | +$1,370 | $236,493 | PHARMACEUTICAL REVERSE DISTRIBUTION AND DESTRUCTION |
| Mod P00015· FUNDING ONLY ACTION | 2021-04-01 | +$757 | $237,251 | PHARMACEUTICAL REVERSE DISTRIBUTION AND DESTRUCTION |
| Mod P00016· FUNDING ONLY ACTION | 2021-04-15 | +$12,331 | $249,581 | PHARMACEUTICAL REVERSE DISTRIBUTION AND DESTRUCTION |
| Mod P00017· FUNDING ONLY ACTION | 2021-05-11 | +$710 | $250,291 | PHARMACEUTICAL REVERSE DISTRIBUTION AND DESTRUCTION |
| Mod P00018· FUNDING ONLY ACTION | 2021-06-15 | +$2,500 | $252,791 | PHARMACEUTICAL REVERSE DISTRIBUTION AND DESTRUCTION |
| Mod P00019· FUNDING ONLY ACTION | 2021-08-18 | +$5,000 | $257,791 | PHARMACEUTICAL REVERSE DISTRIBUTION AND DESTRUCTION |
| Mod P00020· FUNDING ONLY ACTION | 2021-12-22 | −$7,563 | $250,229 | PHARMACEUTICAL REVERSE DISTRIBUTION AND DESTRUCTION |
| Mod P00021· FUNDING ONLY ACTION | 2022-02-03 | −$16,071 | $234,158 | PHARMACEUTICAL REVERSE DISTRIBUTION AND DESTRUCTION |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI D4VCRL38H9C9)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C26026N0056 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · R706 · SUPPORT- MANAGEMENT: LOGISTICS SUPPORT | $19,978 | FY2026 |
| 36C25025P0850 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · Q517 · PHARMACY SERVICES | $7,485 | FY2025 |
| 36C25625P0370 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · Q517 · PHARMACY SERVICES | $3,996 | FY2025 |
| 36C26025D0008 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · R706 · SUPPORT- MANAGEMENT: LOGISTICS SUPPORT | $0 | FY2025 |
| 36C26025N0080 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · R706 · SUPPORT- MANAGEMENT: LOGISTICS SUPPORT | $11,988 | FY2025 |
| 36C24824P0166 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · Q702 · TECHNICAL MEDICAL SUPPORT | $158,346 | FY2024 |
Other recipients under R499 from NETWORK CONTRACT OFFICE 19 (36C259) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C25926N0213 | WERFEN USA LLC | NETWORK CONTRACT OFFICE 19 (36C259) | $20,794 | FY2026 |
| 36C25926N0210 | WERFEN USA LLC | NETWORK CONTRACT OFFICE 19 (36C259) | $48,435 | FY2026 |
| 36C25926N0212 | WERFEN USA LLC | NETWORK CONTRACT OFFICE 19 (36C259) | $98,189 | FY2026 |
| 36C25926N0209 | WERFEN USA LLC | NETWORK CONTRACT OFFICE 19 (36C259) | $31,260 | FY2026 |
| 36C25926N0207 | WERFEN USA LLC | NETWORK CONTRACT OFFICE 19 (36C259) | $62,657 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C25919F0008_3600_36W79718D0002_3600 · retrieved 2026-09-26.